Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 475 of 1294 entries
View as:

Metabolism and Excretion of Liraglutide in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01517568 Org: User:
Start: 11/30/06 End: 12/31/06 Due: 12/31/07

Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT05132088 Org: User:
Start: 11/16/21 End: 09/01/23 Due: 09/01/24

Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083

Phase: N/A Priority: Normal
NCT ID: NCT00715689 Org: User:
Start: 07/31/08 End: 03/31/09 Due: 03/31/10

A Research Study on the Effects of NNC0537-1482 in Healthy Individuals When Injected Under the Skin

Phase: N/A Priority: Normal
NCT ID: NCT06625307 Org: User:
Start: 10/03/24 End: 05/04/25 Due: 05/04/26

Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs

Phase: N/A Priority: Normal
NCT ID: NCT01486862 Org: User:
Start: 10/31/05 End: 07/31/06 Due: 07/31/07

Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT00773279 Org: User:
Start: 09/30/08 End: 06/30/09 Due: 06/30/10

A Trial Evaluating the Blood Glucose-lowering Effect of NN1250 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01154881 Org: User:
Start: 06/30/10 End: 11/30/10 Due: 11/30/11

Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT00184652 Org: User:
Start: 04/30/03 End: 09/30/05 Due: 09/30/06

A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02131246 Org: User:
Start: 05/31/14 End: 07/31/14 Due: 07/31/15

Changing Diabetes in Children

Phase: N/A Priority: Normal
NCT ID: NCT02382757 Org: User:
Start: 09/30/11 End: 11/30/12 Due: 11/30/13

Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process in Healthy Japanese

Phase: N/A Priority: Normal
NCT ID: NCT01620450 Org: User:
Start: 11/20/04 End: 02/26/05 Due: 02/26/06

Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00395746 Org: User:
Start: 10/31/06 End: 05/31/08 Due: 05/31/09

Observational Study of Patients With Diabetes Using Levemir® FlexPen®

Phase: N/A Priority: Normal
NCT ID: NCT00670683 Org: User:
Start: 07/31/07 End: 09/30/09 Due: 09/30/10

A Study to Compare the Blood Levels of Mim8 in Healthy Men When Administered With the DV3407-C1 Pen Injector or a Syringe and Cartridge

Phase: N/A Priority: Normal
NCT ID: NCT05681845 Org: User:
Start: 01/02/23 End: 10/13/23 Due: 10/13/24

To Estimate the Percentage of Children and Adolescents in Tunisia With Acceptably Controlled Diabetes Mellitus Type 1

Phase: N/A Priority: Normal
NCT ID: NCT01493388 Org: User:
Start: 03/31/12 End: 07/31/12 Due: 07/31/13

Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00568074 Org: User:
Start: 12/16/03 End: 09/02/04 Due: 09/02/05

A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT03075644 Org: User:
Start: 03/03/17 End: 10/04/18 Due: 10/04/19

Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00619697 Org: User:
Start: 12/31/03 End: 03/31/05 Due: 03/31/06

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00393718 Org: User:
Start: 11/30/06 End: 05/31/08 Due: 05/31/09

Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01520818 Org: User:
Start: 03/31/00 End: 04/30/01 Due: 04/30/02

First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Medicine Glucagon, in Healthy People.

Phase: N/A Priority: Normal
NCT ID: NCT03444467 Org: User:
Start: 02/05/18 End: 05/24/18 Due: 05/24/19

A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels After a Meal in Type 2 Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT00993304 Org: User:
Start: 10/31/09 End: 12/31/10 Due: 12/31/11

A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden

Phase: N/A Priority: Normal
NCT ID: NCT02077946 Org: User:
Start: 02/10/14 End: 09/03/14 Due: 09/03/15

Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01454024 Org: User:
Start: 11/30/11 End: 10/31/12 Due: 10/31/13

Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03136484 Org: User:
Start: 03/15/17 End: 11/16/18 Due: 11/16/19